AstraZeneca, the drugmaker to mass-produced Oxford University’s potential COVID-19 vaccine, says it could begin supply in September if clinical trials are successful. The…
AstraZeneca, a British-Swedish pharmaceutical firm, and the University of Oxford have entered into an agreement for the global development of a COVID-19 vaccine.…